Healthcare Resource Utilization in Adult Patients with B-Cell Precursor Acute Lymphoblastic Leukemia in First Hematologic Complete Remission with and without Minimal Residual Disease

被引：1
|
作者：
Rose, Darya [1 ]
Shah, Shweta [2 ]
Despiegel, Nicholas [2 ]
Tibrewala, Shruti [1 ]
Chawla, Anita [1 ]
Cong, Ze [2 ]
机构：
[1] Anal Grp Inc, Menlo Pk, CA USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111360
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4732
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Real-world treatment patterns in adult patients (pts) with B-cell precursor acute lymphoblastic leukemia (BCP ALL) in first hematologic complete remission (CR1) with and without minimal residual disease (MRD).
    Shah, Shweta
    Rose, Darya
    Cong, Ze
    Tibrewala, Shruti
    Chawla, Anita
    Zaman, Faraz
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
    Jen, Emily Y.
    Xu, Qing
    Schetter, Aaron
    Przepiorka, Donna
    Shen, Yuan Li
    Roscoe, Donna
    Sridhara, Rajeshwari
    Deisseroth, Albert
    Philip, Reena
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2019, 25 (02) : 473 - 477
  • [3] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Herve
    Bonifacio, Massimiliano
    Reichle, Albrecht
    Graux, Carlos
    Faul, Christoph
    Diedrich, Helmut
    Topp, Max S.
    Brueggemann, Monika
    Horst, Heinz-August
    Havelange, Violaine
    Stieglmaier, Julia
    Wessels, Hendrik
    Haddad, Vincent
    Benjamin, Jonathan E.
    Zugmaier, Gerhard
    Nagorsen, Dirk
    Bargou, Ralf C.
    BLOOD, 2018, 131 (14) : 1522 - 1531
  • [4] Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission
    Urbino, Irene
    Lengline, Etienne
    Rabian, Florence
    Cerrano, Marco
    Kim, Rathana
    Chevillon, Florian
    Ferrero, Dario
    Sebert, Marie
    Dhedin, Nathalie
    Itzykson, Raphael
    Ades, Lionel
    Raffoux, Emmanuel
    Dombret, Herve
    Audisio, Ernesta
    Clappier, Emmanuelle
    Boissel, Nicolas
    BLOOD ADVANCES, 2024, 8 (10) : 2405 - 2409
  • [5] Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease
    Lu, Jialing
    Bao, Xiebing
    Zhou, Jihao
    Li, Xiaoli
    He, Zhewei
    Ji, Yujie
    Xue, Shengli
    Chen, Suning
    Wu, Depei
    Hu, Qi
    Ke, Peng
    Ma, Xiao
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [6] The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia
    Verbeek, Martijn W. C.
    van der Velden, Vincent H. J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [7] Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease
    Bourlon, Christianne
    Lacayo-Lenero, Dennis
    Inclan-Alarcon, Sergio I.
    Demichelis-Gomez, Roberta
    CURRENT ONCOLOGY REPORTS, 2018, 20 (04)
  • [8] Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease
    Christianne Bourlon
    Dennis Lacayo-Leñero
    Sergio I. Inclán-Alarcón
    Roberta Demichelis-Gómez
    Current Oncology Reports, 2018, 20
  • [9] Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Zugmaier, Gerhard
    Dombret, Herve
    Stein, Anthony
    Bonifacio, Massimiliano
    Graux, Carlos
    Faul, Christoph
    Brueggemann, Monika
    Taylor, Kate
    Mergen, Noemi
    Reichle, Albrecht
    Horst, Heinz-August
    Havelange, Violaine
    Topp, Max S.
    Bargou, Ralf C.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2665 - 2673
  • [10] Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
    Zhang, Mingming
    Fu, Huarui
    Lai, Xiaoyu
    Tan, Yamin
    Zheng, Weiyan
    Shi, Jimin
    Zhao, Yanmin
    Lin, Maofang
    He, Jingsong
    Cai, Zhen
    Luo, Yi
    Huang, He
    PLOS ONE, 2016, 11 (10):
12345